& Fryer, A
In sum, while mechanistic plausibility is strong and extrapolation from prostate oncology supports the concept of therapeuticwindow expansion, there is presently no highlevel randomized evidence in cervical/gynecologic oncology showing hydrogels expand the therapeutic window (i.e., allowing higher tumor dose or less toxicity at equivalent tumor dose)
While IV drips may offer quicker results in certain scenarios, capsules provide a practical and effective way to maintain elevated levels of this crucial antioxidant over time
Further, poor solubility, inadequate biodistribution, lower stability, and poor metabolism pose different challenges of toxicity and inefficacy making these methods less effective
MW: 3367.9 g/mol - Ipamorelin: CHNO
These arent internal research or white papers we insist on research that is rigorously conducted by third-parties and universities where the studies are peer-reviewed and published in reputable medical journals